UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2022

 

 

Commission File Number: 001-39633

 

 

Abcam plc

(Translation of registrant’s name into English)

 

 

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F              Form 40-F  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 


INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On February 28, 2022, Abcam plc (the “Company”) issued a regulatory news service announcement (the “Announcement”) announcing its plans to update the market on March 14, 2022 with its full year results for the 12-and 18-month periods ended December 31, 2021. The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.

EXHIBIT INDEX

 

Exhibit
No.

  

Description

99.1    Regulatory News Service Announcement dated February 28, 2022


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ABCAM PLC
Date: February 28, 2022   By:  

/s/ Alan Hirzel

    Name:   Alan Hirzel
    Title:   Chief Executive Officer
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Abcam Charts.
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Abcam Charts.